Downregulation of miR-210-3p attenuates high glucose-induced angiogenesis of vascular endothelial cells via targeting FGFRL1

Conclusion: Our study revealed that miR-210-3p might be a promising target for the treatment of diabetic-associated vascular injury.
Source: Ophthalmic Research - Category: Opthalmology Source Type: research